Jonathan Feng
Ophthalmology · Greenville, NCNPI 1821450073
Payments from drug & device makers
Across 97 payments — averaging $38.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$673
- Notal Vision, Inc.$612
- Alcon$500
- Sun Pharmaceutical Industries Inc.$287
- Biotissue Holdings Inc.$195
- Glaukos Corporation$160
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,291100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 1 | $673 |
| Notal Vision, Inc. | 14 | $612 |
| Alcon | 9 | $500 |
| Sun Pharmaceutical Industries Inc. | 9 | $287 |
| Biotissue Holdings Inc. | 11 | $195 |
| Glaukos Corporation | 4 | $160 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $153 |
| Amgen(2 entities) | 3 | $145 |
| Oyster Point Pharma, Inc. | 1 | $110 |
| Rayner Intraocular Lenses Limited | 5 | $108 |
| Ivantis, Inc | 1 | $105 |
| Mallinckrodt Hospital Products Inc. | 4 | $104 |
| Ocular Therapeutix, Inc. | 4 | $79 |
| ANI Pharmaceuticals, Inc. | 3 | $69 |
| Aerie Pharmaceuticals, Inc. | 5 | $62 |
| Astellas Pharma US Inc | 2 | $59 |
| Bausch & Lomb Americas Inc. | 3 | $56 |
| Rxsight Inc | 2 | $53 |
| AstraZeneca | 3 | $53 |
| Harrow Eye, LLC | 1 | $38 |
| Tarsus Pharmaceuticals, Inc. | 1 | $32 |
| Sight Sciences, Inc. | 1 | $25 |
| Thea Pharma Inc. | 1 | $24 |
| Sanofi | 1 | $21 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $20 |
| Johnson & Johnson Vision Care, Inc. | 1 | $15 |
| Kala Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,771 in reported general payments places this provider in the 70th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MoxifloxacinMoxifloxacin Hcl | 19 | $320 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 16 | $210 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 14 | $177 |
| Latanoprost | 17 | $160 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Greenville
- Glenn JaffeDurham$38.5M
- Lejla VajzovicDurham$7.5M
- Andrew AntoszykCharlotte$4M
- Majda HadziahmetovicDurham$2.4M
- Preeya GuptaRaleigh$2M
- Thomas WilliamsHickory$1.8M
- James HarrisHickory$1.4M
- Rajiv ShahWinston Salem$1.3M
- Patrick KeltyHickory$1.1M
- Julie WoodwardDurham$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.